The Pharma, IT and financial sectors emerged as prominent outperformers, driven by robust earnings growth and a favourable regulatory environment.

The stock gave multibagger returns of 160 per cent in 1 year, 6,855 per cent in 3 years and a whopping 14,000 per cent in 5 years.

The stock gave multibagger returns of over 100 per cent from its 52-week low is Rs 42.55 per share.

According to the financials, the company has a market cap of Rs 92 crore. As of August 2023, the promoters of the company own a 74.99 per cent stake while the rest of the stake is owned by the public (25.01 per cent).

Talking about the financials, the company has a market cap of Rs 190.24 crore with a 3-year CAGR of 39 per cent. The company is almost debt-free and the current debt of the company is just Rs 6.51 crore which is just 3.42 per cent of the market cap.